<map version="0.8.0">
    <!-- To view this file, download free mind mapping software FreeMind from http://freemind.sourceforge.net -->
    <node CREATED="1170417268844" ID="Freemind_Link_298659209" MODIFIED="1170417280371" TEXT="Aesica">
        <node CREATED="1170417282003" FOLDED="true" ID="_" LINK="http://www.aesica-pharma.co.uk/" MODIFIED="1174055867136" POSITION="right" TEXT="&lt;html&gt;Contact Details&#xa;">
            <node CREATED="1170417499666" ID="Freemind_Link_1476478906" MODIFIED="1170417526184" TEXT="&lt;html&gt;&lt;b&gt;Address&lt;/b&gt;&lt;br&gt;Aesica Pharmaceuticals Ltd&lt;br&gt; Shotton Lane&lt;br&gt; Windmill Industrial Estate&lt;br&gt; Cramlington&lt;br&gt; Northumberland&lt;br&gt; NE23 3JL" />
        </node>
        <node CREATED="1170417292378" FOLDED="true" ID="Freemind_Link_107162829" MODIFIED="1170525181424" POSITION="left" TEXT="Chemistry">
            <font NAME="SansSerif" SIZE="13" />
            <node CREATED="1170434170270" FOLDED="true" ID="Freemind_Link_342146602" MODIFIED="1177506838352" TEXT="APIs">
                <font NAME="SansSerif" SIZE="13" />
                <node CREATED="1170434200524" FOLDED="true" ID="Freemind_Link_1205575098" MODIFIED="1170434205401" TEXT="NSAIDs">
                    <node CREATED="1170434588742" FOLDED="true" ID="Freemind_Link_718680012" MODIFIED="1170434604535" TEXT="Flurbiprofen">
                        <node CREATED="1170434310892" FOLDED="true" ID="Freemind_Link_1640417792" MODIFIED="1177714286429" TEXT="&lt;html&gt;Aesica Pharmaceuticals has been granted a Certificate of Suitability&lt;br&gt;&#xa;for Flurbiprofen by the European Directorate for the Quality of&lt;br&gt;&#xa;Medicines (EDQM). The certificate, number R0-CEP 2003-270-Rev 00,&lt;br&gt;&#xa;was awarded on the 24th March 2006 and confirms that Aesica&apos;s&lt;br&gt;&#xa;Flurbiprofen is compliant with the requirements of the European&lt;br&gt;&#xa;Pharmacopoeial monograph.&lt;br&gt;&#xa;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/1/1d/Flurbiprofen.gif&quot;&gt;">
                            <node CREATED="1170524282191" FOLDED="true" ID="Freemind_Link_928366036" LINK="http://www.google.com/patents?vid=USPAT3755427&amp;id=lasyAAAAEBAJ&amp;dq=3,755,427" MODIFIED="1170528065922" TEXT="&lt;html&gt;The Merck Index 12&lt;sup&gt;th&lt;/sup&gt; ed&lt;br&gt;&#xa;4234 Flurbiprofen US pat &lt;b&gt;3,755,427&lt;/b&gt;&lt;br&gt;&#xa;to Boots">
                                <node CREATED="1170531112943" FOLDED="true" ID="Freemind_Link_789696418" LINK="http://www.google.com/patents?vid=USPAT3755427&amp;id=lasyAAAAEBAJ&amp;printsec=description&amp;zoom=4&amp;dq=3,755,427#PPP3,M1" MODIFIED="1177714223008" TEXT="&lt;html&gt;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/f/f3/Flurbiprofenscheme.gif&quot;&gt;">
                                    <node CREATED="1170531355572" ID="Freemind_Link_1587812586" MODIFIED="1170531376653" TEXT="&lt;html&gt;&lt;b&gt;There must be a better synthesis!&lt;/b&gt;" />
                                </node>
                            </node>
                        </node>
                    </node>
                    <node CREATED="1170434626556" FOLDED="true" ID="Freemind_Link_768758049" MODIFIED="1170434630211" TEXT="Sodium Flurbiprofen ">
                        <node CREATED="1170524321087" ID="Freemind_Link_571989593" MODIFIED="1170524323571" TEXT="&lt;html&gt;&lt;b&gt;Require synthesis details&lt;/b&gt;" />
                    </node>
                    <node CREATED="1170434647657" FOLDED="true" ID="Freemind_Link_1442585622" MODIFIED="1170434653655" TEXT="R-Flurbiprofen">
                        <node CREATED="1170434657411" FOLDED="true" ID="Freemind_Link_1438355152" MODIFIED="1177714113501" TEXT="&lt;html&gt;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/2/2d/R-flurbiprofen.gif&quot;&gt;">
                            <node CREATED="1170438881875" ID="Freemind_Link_959069616" LINK="http://www.myriad.com/" MODIFIED="1170438918418" TEXT="Myriad Pharmaceuticals Inc and Flurizan&#xae;" />
                            <node CREATED="1170524335047" ID="Freemind_Link_1564352429" MODIFIED="1170524338042" TEXT="&lt;html&gt;&lt;b&gt;Require synthesis details&lt;/b&gt;" />
                        </node>
                    </node>
                    <node CREATED="1170434729204" FOLDED="true" ID="Freemind_Link_390508942" MODIFIED="1170434731707" TEXT="S-Flurbiprofen">
                        <node CREATED="1170524343690" ID="Freemind_Link_795081010" MODIFIED="1170524345683" TEXT="&lt;html&gt;&lt;b&gt;Require synthesis details&lt;/b&gt;" />
                    </node>
                </node>
                <node CREATED="1170434764885" FOLDED="true" ID="Freemind_Link_240537530" MODIFIED="1170434773968" TEXT="Paroxetine">
                    <node CREATED="1170434804392" FOLDED="true" ID="Freemind_Link_1710504414" MODIFIED="1177713355471" TEXT="&lt;html&gt;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/c/c0/Paroxetine-hcl.gif&quot;&gt;&lt;br&gt;&#xa;Paroxetine is an antidepressant of the&lt;br&gt;&#xa;selective serotonin reuptake inhibitor&lt;br&gt;&#xa;(SSRI) type. It is effective in treating&lt;br&gt;&#xa;depression as well as a spectrum of&lt;br&gt;&#xa;anxiety disorders ranging from panic&lt;br&gt;&#xa;attacks to phobias.">
                        <node CREATED="1170524351541" FOLDED="true" ID="Freemind_Link_907187879" MODIFIED="1170532541858" TEXT="&lt;html&gt;&lt;b&gt;Merk Index 12&lt;sup&gt;th&lt;/sup&gt; ed&lt;br&gt;&#xa;US pats 3,912,743; 4,007,196&lt;/b&gt; (1974, 1975,&lt;br&gt;&#xa;1977 all to Ferrosan); &lt;b&gt;4,721,723&lt;/b&gt; (Beecham)">
                            <node CREATED="1170599166805" FOLDED="true" ID="Freemind_Link_1916868152" MODIFIED="1170599189027" TEXT="&lt;html&gt;&lt;b&gt;US 3,912,743&lt;/b&gt;">
                                <node CREATED="1170532546645" FOLDED="true" ID="Freemind_Link_16849974" LINK="http://www.google.com/patents?vid=USPAT3912743&amp;id=LBs3AAAAEBAJ&amp;dq=3,912,743&amp;jtp=1#PPA66,M1" MODIFIED="1177713545304" TEXT="&lt;html&gt;&lt;b&gt; US 3,912,743&lt;/b&gt;&lt;br&gt;&#xa;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/5/50/Paroxetine3912743.gif&quot;&gt;">
                                    <node CREATED="1170599215175" ID="Freemind_Link_136231535" LINK="http://www.google.com/patents?vid=USPAT2506458&amp;id=Wn9iAAAAEBAJ&amp;printsec=abstract&amp;zoom=4&amp;dq=2506458#PPA59,M1" MODIFIED="1170600037668" TEXT="&lt;html&gt;&lt;b&gt;US 2,506,458 - Arecoline&lt;/b&gt;" />
                                    <node CREATED="1170599329880" ID="Freemind_Link_433133430" LINK="http://www.google.com/patents?vid=USPAT2569182&amp;id=a_ZlAAAAEBAJ&amp;printsec=abstract&amp;zoom=4&amp;dq=2506458#PPR1,M1" MODIFIED="1170599387463" TEXT="&lt;html&gt;&lt;b&gt;US 2,569,182 - Arecoline&lt;/b&gt;" />
                                </node>
                            </node>
                            <node CREATED="1170599444435" FOLDED="true" ID="Freemind_Link_1300905415" MODIFIED="1170599471564" TEXT="&lt;html&gt;&lt;b&gt;US 4,007,196&lt;/b&gt;">
                                <node CREATED="1170539100840" FOLDED="true" ID="Freemind_Link_747339528" LINK="http://www.google.com/patents?vid=USPAT4007196&amp;id=BIU1AAAAEBAJ&amp;dq=4,007,196" MODIFIED="1177713771779" TEXT="&lt;html&gt;US 4,007,196 Menthol ester resolution to give SM&lt;br&gt;&#xa;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/f/f1/US4007196.gif&quot;&gt;&lt;br&gt;&#xa;Converted to secondary chloride in order to couple.">
                                    <node CREATED="1173533819159" ID="Freemind_Link_756234069" LINK="..\Aesica\US4007196.pdf" MODIFIED="1173533875680" TEXT="&lt;html&gt;PDF of Patent" />
                                </node>
                            </node>
                            <node CREATED="1170599485033" FOLDED="true" ID="Freemind_Link_1886321550" MODIFIED="1170599507215" TEXT="&lt;html&gt;&lt;b&gt;US 4,721,723&lt;/b&gt;">
                                <node CREATED="1170539151052" FOLDED="true" ID="Freemind_Link_672990489" LINK="http://www.google.com/patents?vid=USPAT4721723&amp;id=43UaAAAAEBAJ&amp;dq=4,721,723" MODIFIED="1177713919572" TEXT="&lt;html&gt;US 4,721,723&lt;br&gt;&#xa;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/8/87/US4721723.gif&quot;&gt;">
                                    <node CREATED="1173531412869" ID="Freemind_Link_703679039" LINK="..\Aesica\US4721723.pdf" MODIFIED="1173531510529" TEXT="US4,721,723 PDF Document" />
                                </node>
                            </node>
                            <node CREATED="1173520723308" FOLDED="true" ID="Freemind_Link_672970066" MODIFIED="1173520750707" TEXT="&lt;html&gt;&lt;b&gt;WO 96/36636&lt;/b&gt;">
                                <node CREATED="1173520757247" ID="Freemind_Link_1936472669" LINK="http://v3.espacenet.com/results?sf=n&amp;FIRST=1&amp;F=0&amp;CY=gb&amp;LG=en&amp;DB=EPODOC&amp;PN=WO9636636&amp;Submit=SEARCH&amp;=&amp;=&amp;=&amp;=&amp;=" MODIFIED="1177714019986" TEXT="&lt;html&gt;Condensation, Prins, resolution, reduction, substitution, deprotection&lt;br&gt;&#xa;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/8/88/WO9636636.gif&quot;&gt;" />
                            </node>
                        </node>
                    </node>
                </node>
                <node CREATED="1170435013723" FOLDED="true" ID="Freemind_Link_864002176" MODIFIED="1170435119305" TEXT="Dothiepin">
                    <node CREATED="1170435017038" FOLDED="true" ID="Freemind_Link_1713208912" MODIFIED="1177711948237" TEXT="&lt;html&gt;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/d/d6/Dothiepin-hcl.gif&quot;&gt;&lt;br&gt;&#xa;Dothiepin (dosulepin) is a well&lt;br&gt;&#xa;trusted tricyclic anti-depressant&lt;br&gt;&#xa;with some tranquillising properties.">
                        <node CREATED="1170524363969" FOLDED="true" ID="Freemind_Link_1255383360" LINK="http://www.google.com/patents?vid=USPAT3527766&amp;id=f5R1AAAAEBAJ&amp;dq=3,527,766" MODIFIED="1177589008363" TEXT="&lt;html&gt;&lt;b&gt;US 3,527,766&lt;/b&gt;&lt;br&gt;&#xa;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/0/00/Dothiepinscheme.gif&quot;&gt;">
                            <node CREATED="1170586588049" ID="Freemind_Link_1076482239" MODIFIED="1170661737677" TEXT="&lt;html&gt;&lt;b&gt;Synthesis of starting material:-&lt;/b&gt;&lt;br&gt;&#xa;benzenethiol and 2-chloromethyl-benzoic acid or&lt;br&gt;&#xa;3&lt;i&gt;H&lt;/i&gt;-Isobenzofuran-1-one (alkyl vs acyl attack)? &#xa;&#xa;" />
                        </node>
                    </node>
                </node>
            </node>
        </node>
        <node CREATED="1170417297796" FOLDED="true" ID="Freemind_Link_1879896860" MODIFIED="1170417304295" POSITION="right" TEXT="Ownership Details">
            <node CREATED="1170435317640" FOLDED="true" ID="Freemind_Link_623534901" MODIFIED="1170435398857" TEXT="&lt;html&gt;Aesica Limited&lt;br&gt;&#xa;03600002">
                <node CREATED="1170435836085" ID="Freemind_Link_1195415918" MODIFIED="1170435870996" TEXT="&lt;html&gt;Name &amp; Registered Office:&lt;br&gt;&#xa;AESICA LIMITED C/O JOHN MARSHALL &amp; CO&lt;br&gt;&#xa;6 BELL VILLAS, PONTELAND&lt;br&gt;&#xa;NEWCASTLE UPON TYNE NE20 9BE&lt;br&gt;&#xa;Company No. 03600002" />
                <node CREATED="1170435890113" ID="Freemind_Link_662787526" MODIFIED="1170435893428" TEXT="Status: Active Date of Incorporation: 17/07/1998  Country of Origin: United Kingdom Company Type: Private Limited Company Nature of Business (SIC(03)): 5530 - Restaurants Accounting Reference Date: 31/03 Last Accounts Made Up To: 31/03/2006  (TOTAL EXEMPTION SMALL) Next Accounts Due: 31/01/2008 Last Return Made Up To: 17/07/2006 Next Return Due: 14/08/2007 Last Members List: 17/07/2006 Previous Names: No previous name information has been recorded over the last 20 years." />
                <node CREATED="1170524501567" ID="Freemind_Link_1878163624" MODIFIED="1170524543958" TEXT="&lt;html&gt;&lt;b&gt;Restaurant?&lt;/b&gt;" />
            </node>
            <node CREATED="1170435325972" FOLDED="true" ID="Freemind_Link_768276774" MODIFIED="1170435447967" TEXT="&lt;html&gt;Aesica Pharmaceuticals Limited&lt;br&gt;&#xa;05188033">
                <node CREATED="1170435541892" ID="Freemind_Link_957707262" LINK="http://wck2.companieshouse.gov.uk/fbe37af914d35ccc516040ef1b9acf56/compdetails" MODIFIED="1170435597673" TEXT="&lt;html&gt;Name &amp; Registered Office: AESICA PHARMACEUTICALS LIMITED&lt;br&gt;&#xa;WINDMILL INDUSTRIAL ESTATE CRAMLINGTON&lt;br&gt;&#xa;NORTHUMBERLAND NE23 3JL&lt;br&gt;&#xa;Company No. 05188033" />
                <node CREATED="1170435634746" FOLDED="true" ID="Freemind_Link_408833388" MODIFIED="1170436128476" TEXT="&lt;html&gt;Status: Active Date of Incorporation: 23/07/2004&lt;br&gt;&#xa;Country of Origin: United Kingdom&lt;br&gt;&#xa;Company Type: Private Limited Company&lt;br&gt;&#xa;Nature of Business (SIC(03)): 2441 -&lt;br&gt;&#xa;Manufacture of basic pharmaceutical prods&lt;br&gt;&#xa;Accounting Reference Date: 31/08 Last Accounts&lt;br&gt;&#xa;Made Up To: 31/08/2005  (FULL) Next Accounts Due:&lt;br&gt;&#xa;30/06/2007 Last Return Made Up To: 23/07/2006&lt;br&gt;&#xa;Next Return Due: 20/08/2007 Last Members List:&lt;br&gt;&#xa;23/07/2006 Previous Names: Date of change&lt;br&gt;&#xa;Previous Name 17/08/2004 &lt;u&gt;EVER 2414 LIMITED&lt;/u&gt;">
                    <node CREATED="1170436090501" FOLDED="true" ID="Freemind_Link_1575172066" MODIFIED="1170436108257" TEXT="&lt;html&gt;EVER 2414 Limited">
                        <node CREATED="1170436160382" ID="Freemind_Link_1933950841" MODIFIED="1170436194250" TEXT="&lt;html&gt;Name &amp; Registered Office: EVER 2414 LIMITED&lt;br&gt;&#xa;CENTRAL SQUARE SOUTH ORCHARD STREET&lt;br&gt;&#xa;NEWCASTLE UPON TYNE NE1 3XX&lt;br&gt;&#xa;Company No. 04739682" />
                        <node CREATED="1170436212517" ID="Freemind_Link_164227528" MODIFIED="1170436336325" TEXT="&lt;html&gt;Status: Dissolved 04/10/2005 Date of Incorporation: 18/04/2003&lt;br&gt;&#xa;Country of Origin: United Kingdom Company Type: Private Limited Company&lt;br&gt;&#xa;Nature of Business (SIC(03)): 2441 - Manufacture of basic pharmaceutical prods&lt;br&gt;&#xa;Accounting Reference Date: 30/04 Last Accounts Made Up To:&lt;br&gt;&#xa;(NO ACCOUNTS FILED) Next Accounts Due: 18/02/2005 Last Return&lt;br&gt;&#xa;Made Up To: 18/04/2004 Next Return Due: 16/05/2005 Last Members List:&lt;br&gt;&#xa;18/04/2004 Previous Names: Date of change&lt;br&gt;&#xa;Previous Name 17/08/2004 &#x9;AESICA PHARMACEUTICALS LIMITED 29/01/2004&lt;br&gt;&#xa;&lt;u&gt;EVER 2083 LIMITED&lt;/u&gt;" />
                    </node>
                </node>
            </node>
            <node CREATED="1170435343597" FOLDED="true" ID="Freemind_Link_672584515" MODIFIED="1170435475397" TEXT="&lt;html&gt;Aesica Trustee Company Limited&lt;br&gt;&#xa;05649537">
                <node CREATED="1170435955697" ID="Freemind_Link_981747966" MODIFIED="1170435987423" TEXT="&lt;html&gt;Name &amp; Registered Office: AESICA TRUSTEE COMPANY LIMITED&lt;br&gt;&#xa;AESICA PHARMACEUTICALS LIMITED&lt;br&gt;&#xa;WINDMILL INDUSTRIAL ESTATE CRAMLINGTON&lt;br&gt;&#xa;NORTHUMBERLAND NE23 3JL Company No. 05649537" />
                <node CREATED="1170436002885" ID="Freemind_Link_521375120" MODIFIED="1170436005259" TEXT="Status: Active Date of Incorporation: 08/12/2005  Country of Origin: United Kingdom Company Type: Private Limited Company Nature of Business (SIC(03)): 2441 - Manufacture of basic pharmaceutical prods Accounting Reference Date: 31/12 Last Accounts Made Up To:  (NO ACCOUNTS FILED) Next Accounts Due: 08/10/2007 Last Return Made Up To: 08/12/2006 Next Return Due: 05/01/2008 Last Members List: 08/12/2006 Previous Names: No previous name information has been recorded over the last 20 years." />
            </node>
            <node CREATED="1170436706317" ID="Freemind_Link_935652134" MODIFIED="1170524585347" TEXT="&lt;html&gt;&lt;b&gt;Note&lt;/b&gt;&lt;br&gt;&#xa;Eversheds (Lawyers) Central Square South&lt;br&gt;&#xa;Orchard Street&lt;br&gt;&#xa;Newcastle upon Tyne&lt;br&gt;&#xa;NE1 3XX United Kingdom" />
        </node>
        <node CREATED="1170417306909" FOLDED="true" ID="Freemind_Link_1765713138" MODIFIED="1170524875034" POSITION="left" TEXT="&lt;html&gt;&lt;b&gt;Patent Portfolio&lt;/b&gt;">
            <font NAME="SansSerif" SIZE="13" />
            <icon BUILTIN="help" />
            <node CREATED="1170437688129" FOLDED="true" ID="Freemind_Link_648481634" LINK="http://gb.espacenet.com/" MODIFIED="1170524881713" TEXT="&lt;html&gt;Espace Search 02-Feb-2007&lt;br&gt;&#xa;3 patents">
                <node CREATED="1170437772420" ID="Freemind_Link_839937025" LINK="http://v3.espacenet.com/textdoc?DB=EPODOC&amp;IDX=DE50011819D&amp;F=0" MODIFIED="1170437878122" TEXT="&lt;html&gt;&lt;b&gt;STABLE PHARMACEUTICAL APPLICATION FORM FOR PAROXETIN ANHYDRATE&lt;/b&gt;&lt;br&gt;&#xa;&quot;The invention relates to medicaments containing paroxetin anhydrate or&lt;br&gt;&#xa;pharmaceutically compatible salts thereof and lipophiles and/or semi-lipophilic carriers.&quot;">
                    <font NAME="SansSerif" SIZE="12" />
                </node>
                <node CREATED="1170437919201" FOLDED="true" ID="Freemind_Link_1564463041" LINK="http://v3.espacenet.com/textdoc?DB=EPODOC&amp;IDX=HR20030227&amp;F=0" MODIFIED="1177714395907" TEXT="&lt;html&gt;&lt;b&gt;PROCESS FOR THE RACEMISATION OF 1-BENZYL-4-(4-FLUOROPHENYL)-3-HYDROXYMETHYL-&lt;br&gt;&#xa;1,2,3,6-TETRAHYDROPYRIDINE TO BE USED AS INTERMEDIATE IN THE SYNTHESIS OF PAROXETINE&lt;/b&gt;&lt;br&gt;&#xa;&quot;A process for the racemisation of enantiomerically enriched 1-benzyl-4-(4-fluorophenyl)-3-&lt;br&gt;&#xa;hydroxymethyl-1,2,3,6-tetrahydropyridine which is a useful intermediate in the preparation&lt;br&gt;&#xa;of paroxetine. Formula (A) means that the compound (I) has an enantiomeric excess of one&lt;br&gt;&#xa;enantiomer over the other enantiomer. R1 and R2 are defined as in claim 1.&quot;&lt;br&gt;&#xa;&lt;img src=&quot;http://freemind.sourceforge.net/wiki/images/8/8e/US6949650.gif&quot;&gt;">
                    <node CREATED="1173392219892" ID="Freemind_Link_1394056062" LINK="..\Aesica\US6949650.pdf" MODIFIED="1173537235431" TEXT="&lt;html&gt;US6949650, pdf local drive" />
                </node>
                <node CREATED="1170438289443" FOLDED="true" ID="Freemind_Link_412788238" LINK="http://v3.espacenet.com/textdoc?DB=EPODOC&amp;IDX=HU0402368&amp;F=0" MODIFIED="1170438399822" TEXT="&lt;html&gt;&lt;b&gt;RECOVERY AND RECYCLING OF CHIRAL TARTARIC ACID RESOLVING AGENTS&lt;/b&gt;&lt;br&gt;&#xa;&quot;A process for the recovery of substituted tartaric acid resolving agents from&lt;br&gt;&#xa;resolution process liquors comprising organic solvents, wherein the&lt;br&gt;&#xa;substituted tartaric acid derivatives are neutralised by adding a base,&lt;br&gt;&#xa;extracted into an aqueous phase and crystallised from the aqueous phase&lt;br&gt;&#xa;by addition of a mineral acid in the presence of an organic solvent.&quot;">
                    <node CREATED="1173393271014" ID="Freemind_Link_1340206853" LINK="..\Aesica\USApp20050085665-1.pdf" MODIFIED="1173393314626" TEXT="USApp20050085665-1" />
                </node>
            </node>
            <node CREATED="1174062543777" FOLDED="true" ID="Freemind_Link_866331360" LINK="http://assignments.uspto.gov/assignments/q?db=pat&amp;qt=asne&amp;reel=&amp;frame=&amp;pat=&amp;pub=&amp;asnr=&amp;asnri=&amp;asne=Aesica&amp;asnei=&amp;asns=" MODIFIED="1174062620797" TEXT="&lt;html&gt;5 patents from USPTO Assignee &quot;Aesica&quot;&lt;br&gt;&#xa;search conducted 16th March 2007">
                <node CREATED="1174062769141" ID="Freemind_Link_495195099" LINK="http://assignments.uspto.gov/assignments/q?db=pat&amp;asned=AESICA%20PHARMACEUTICALS" MODIFIED="1174070054456" TEXT="&lt;html&gt;10495359  NONE  US20050085665  AESICA PHARMACEUTICALS " />
                <node CREATED="1174062771915" ID="Freemind_Link_750310359" LINK="http://assignments.uspto.gov/assignments/q?db=pat&amp;asned=AESICA%20PHARMCEUTICALS%20LTD." MODIFIED="1174070136705" TEXT="&lt;html&gt;10362531  6949650  US20040014786  AESICA PHARMCEUTICALS LTD. " />
                <node CREATED="1174062775269" ID="Freemind_Link_594640832" LINK="http://assignments.uspto.gov/assignments/q?db=pat&amp;asned=AESICA%20PHARMACEUTICALS%20LTD." MODIFIED="1174070222909" TEXT="&lt;html&gt;09423749  6326496  AESICA PHARMACEUTICALS LTD. " />
                <node CREATED="1174062779716" ID="Freemind_Link_937409138" LINK="http://assignments.uspto.gov/assignments/q?db=pat&amp;asned=AESICA%20PHARMACEUTICALS%20LTD." MODIFIED="1174070284888" TEXT="&lt;html&gt;09949899  6596309  US20020058063  AESICA PHARMACEUTICALS LTD. " />
                <node CREATED="1174062782360" ID="Freemind_Link_1589904267" LINK="http://assignments.uspto.gov/assignments/q?db=pat&amp;asned=AESICA%20PHARMACEUTICALS,%20LTD." MODIFIED="1174070345535" TEXT="&lt;html&gt;08424517  5599969  AESICA PHARMACEUTICALS, LTD.&#xa;" />
            </node>
        </node>
        <node CREATED="1170417316713" FOLDED="true" ID="Freemind_Link_590156759" MODIFIED="1170525176627" POSITION="right" TEXT="Lexis-Nexis Butterworth (LNB) Search">
            <node CREATED="1170524381144" ID="Freemind_Link_423458169" MODIFIED="1171281891675" TEXT="&lt;html&gt;12&lt;sup&gt;th&lt;/sup&gt; Feb 2007.  1 - 49 (note not all may be relevant to this company).&lt;br&gt;&#xa;&lt;ol type=&quot;i&quot;&gt;&lt;li&gt;Turbine Trouble, Evening Chronicle 02-Feb-2007.&lt;br&gt;&#xa;Planning permission refused to have a wind turbine.&lt;br&gt;&#xa;The story slightly misses the point &quot;Drugs companies&lt;br&gt;&#xa;in Northumberland hoping to slash their energy bills&lt;br&gt;&#xa;by installing turbines ...&quot;  At the time of writing in the UK&lt;br&gt;&#xa;a lot of money can be made through ROCs (Renewable&lt;br&gt;&#xa;Energy Obligation Certificates.  Saving energy is a usually&lt;br&gt;&#xa;a secondary consideration.&#xa;&lt;li&gt;Flight Fears block plans to cut bills, 1-Feb-2007&lt;br&gt;&#xa;see above.&#xa;&lt;li&gt;Second Firm Bids for Windturbines 17-Jan-2007&#xa;&lt;li&gt;13-Dec-2006 &quot;PHARMACEUTICAL company Aesica will&lt;br&gt;&#xa;nearly double its revenues after buying a factory in north&lt;br&gt;&#xa;London from industry giant Merck &amp; Co.&lt;br&gt;&#xa;&#xa;Aesica, based in Cramlington, Northumberland, is to take&lt;br&gt;&#xa;over Merck&apos;s facility at Ponders End, in Enfield, north London,&lt;br&gt;&#xa;for an undisclosed sum. The deal is expected to take&lt;br&gt;&#xa;Aesica&apos;s turnover to between &#xa3;50m and &#xa3;60m. The company&lt;br&gt;&#xa;will also be hiring new staff.&lt;br&gt;&#xa;&#xa;Its Cramlington site, bought out from BASF in 2004, currently&lt;br&gt;&#xa;employs around 160 direct employees, and Aesica will take&lt;br&gt;&#xa;on another 74 in Enfield from Merck, as well as hiring at least&lt;br&gt;&#xa;another 20 staff there over the next few months.&quot;&lt;/ol&gt;" />
            <node CREATED="1171282274365" ID="Freemind_Link_867915396" MODIFIED="1173535349109" TEXT="&lt;html&gt;Drug firm delighted by 10-year contract  BYLINE: By Graeme King, The Journal  SECTION: &lt;br&gt;&#xa;BUSINESS LOCAL, Pg. 3  LENGTH: 352 words       A multi-million pound deal for a&lt;br&gt;Northumberland drug company has given the industry a lift just days after rival Pfizer&lt;br&gt;&#xa;announced it was selling up in Morpeth, putting 600 jobs in jeopardy.  Aesica&lt;br&gt;&#xa;Pharmaceuticals from Cramlington has signed a 10-year deal with US company Myriad&lt;br&gt;&#xa;Pharmaceuticals to supply an ingredient for its new anti-Alzheimer&apos;s drug.  Chief executive&lt;br&gt;&#xa;Dr Robert Hardy said the deal was a great achievement just five months after Aesica was&lt;br&gt;&#xa;created in a management buy-out from BASF.   And there is a good chance Aesica&apos;s&lt;br&gt;&#xa;140-strong team could grow if demand for the Flurizan product still being tested in clinical&lt;br&gt;&#xa;trials is as strong as expected.  Aesica has already taken on a handful of new staff for&lt;br&gt;&#xa;projects it is currently working on, and Dr Hardy said there could be more to come.  He&lt;br&gt;&#xa;said: &lt;b&gt;&quot;Depending on how big this grows, there could be expansion on site here in the&lt;br&gt;&#xa;future.  &quot;This deal secures a longer term future for us. If this is successful, we&apos;ve got&lt;br&gt;&#xa;business for 10 years, rather than for the shorter term.  &quot;Those products we have at the&lt;br&gt;&#xa;moment are very good, but in five to six years more, they won&apos;t be making the returns they&lt;br&gt;&#xa;are now.&quot;  The massive deal is important for 35m turnover Aesica as its current products&lt;br&gt;&#xa;only have a shelf life of around five to six years, and new products are needed to secure&lt;br&gt;&#xa;the long term future of the workforce.  Dr Hardy said: &lt;u&gt;&quot;It&apos;s very important to come up with a&lt;br&gt;&#xa;pipeline of new products.&lt;/u&gt;&lt;/b&gt; It&apos;s clearly one of our prime objectives. The company is achieving&lt;br&gt;&#xa;everything we expected it to. We are well ahead of where we expected to be with new&lt;br&gt;&#xa;products, and we are looking at another product as well as this one.  &quot;Flurizan is potentially&lt;br&gt;&#xa;a blockbuster in terms of sales for Myriad and we have a 10-year agreement as primary&lt;br&gt;&#xa;supplier.&quot;  Dr Hardy said early indications were that Flurizan was effective for Alzheimer&apos;s&lt;br&gt;&#xa;and also for prostate cancer. Dr Hardy said Aesica was very content to be located in the&lt;br&gt;&#xa;North-East and he did not think the loss of Pfizer was any reflection of the business&lt;br&gt;&#xa;environment in the region.   LOAD-DATE: February 3, 2005  LANGUAGE: ENGLISH&lt;br&gt;&#xa;Copyright 2005 Newcastle Chronicle &amp; Journal Ltd" />
        </node>
        <node CREATED="1170435226809" FOLDED="true" ID="Freemind_Link_1871203656" MODIFIED="1170435231316" POSITION="left" TEXT="Quality">
            <node CREATED="1170435253327" FOLDED="true" ID="Freemind_Link_1573016470" MODIFIED="1170435257363" TEXT="cGMP">
                <node CREATED="1173432006817" ID="Freemind_Link_519073314" LINK="http://ec.europa.eu/enterprise/pharmaceuticals/eudralex/vol-4/pdfs-en/2005_10_03_gmp-partii-activesubstance.pdf" MODIFIED="1173432088765" TEXT="&lt;html&gt;EU Link&lt;br&gt;&lt;br&gt;&#xa;EudraLex&lt;br&gt;&#xa;The Rules Governing Medicinal Products in the European Union&lt;br&gt;&#xa;Volume 4&lt;br&gt;&#xa;EU Guidelines to&lt;br&gt;&#xa;Good Manufacturing Practice&lt;br&gt;&#xa;Medicinal Products for Human and Veterinary Use&lt;br&gt;&#xa;Part II&lt;br&gt;&#xa;Basic Requirements for Active Substances used as Starting Materials" />
                <node CREATED="1170435282149" ID="Freemind_Link_1866627291" MODIFIED="1170435289229" TEXT="Iso 9000 - 2000" />
                <node CREATED="1170435266697" ID="Freemind_Link_883839187" MODIFIED="1170435269060" TEXT="MHRA" />
            </node>
            <node CREATED="1170435260898" ID="Freemind_Link_266245829" MODIFIED="1170435264423" TEXT="FDA" />
        </node>
        <node CREATED="1170437333779" FOLDED="true" ID="Freemind_Link_1793963110" MODIFIED="1170437337304" POSITION="right" TEXT="Management">
            <node CREATED="1170437345997" FOLDED="true" ID="Freemind_Link_897286398" MODIFIED="1170437388498" TEXT="&lt;html&gt;&lt;ul&gt;&lt;li&gt;    * Robert Hardy, Managing Director    &lt;li&gt; * Adam Sims, Finance Director    &lt;li&gt; * Alan Rankin, Sales and Marketing Director    &lt;li&gt; * Chris Gowland, Operations Director  &lt;li&gt;  * John McConnell, Human Resources Director&lt;/ul&gt;">
                <node CREATED="1170524421642" ID="Freemind_Link_1979004604" MODIFIED="1170524433309" TEXT="&lt;html&gt;&lt;b&gt;LNB Pending&lt;/b&gt;" />
            </node>
            <node CREATED="1173534212344" ID="Freemind_Link_437341317" MODIFIED="1174055721276" TEXT="&lt;html&gt;&lt;b&gt;Questions&lt;/b&gt;&lt;ul&gt;&#xa;&lt;li&gt;Why two companies (trust and pharma Co)?&#xa;&lt;li&gt;Where is the future direction of the company?&lt;ul&gt;&#xa;&lt;li&gt;Is it only acquisition, or&#xa;&lt;li&gt;innovation?&lt;/ul&gt;&#xa;&lt;li&gt;&lt;b&gt;&lt;u&gt;&quot;It&apos;s very important to come up with a&lt;br&gt;&#xa;pipeline of new products.&lt;/u&gt;&lt;/b&gt;&quot;  How?&#xa;&lt;li&gt;Where are sources of competitive intelligence&lt;br&gt;&#xa;and hence strategic planning&#xa;&lt;ul&gt;&#xa;&lt;li&gt;Aesica, or&#xa;&lt;li&gt;Backers?&lt;/ul&gt;&#xa;&lt;li&gt;What is known about the banker&apos;s portfolio (ie&lt;br&gt;&#xa;do they have any other pharma Cos on their&lt;br&gt;&#xa;books)?&#xa;&lt;li&gt;How important were the wind turbines (ie&lt;br&gt;&#xa;ROCs) to Aesica Cash flow?&#xa;&lt;li&gt;&lt;b&gt;US6949650&lt;/b&gt; Who were the inventors?&#xa;&lt;/ul&gt;">
                <arrowlink DESTINATION="Freemind_Link_437341317" ENDARROW="Default" ENDINCLINATION="0;0;" ID="Freemind_Arrow_Link_840472373" STARTARROW="None" STARTINCLINATION="0;0;" />
                <icon BUILTIN="help" />
            </node>
        </node>
        <node CREATED="1170523490733" ID="Freemind_Link_1063247343" MODIFIED="1177505093793" POSITION="left" TEXT="&lt;html&gt;&#xa;&lt;b&gt;Note&lt;/b&gt;  Very much a &lt;i&gt;work in progress&lt;/i&gt;." />
    </node>
</map>